Nathan R Foster

Nathan R Foster

UNVERIFIED PROFILE

Are you Nathan R Foster?   Register this Author

Register author
Nathan R Foster

Nathan R Foster

Publications by authors named "Nathan R Foster"

Are you Nathan R Foster?   Register this Author

64Publications

1359Reads

5Profile Views

Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development.

EBioMedicine 2019 Nov 6. Epub 2019 Nov 6.

The Hormel Institute, University of Minnesota, 801 16th Ave NE, Austin, MN 55912, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.10.038DOI Listing
November 2019

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).

J Clin Oncol 2018 05 27;36(14):1412-1418. Epub 2018 Mar 27.

Brigette B.Y. Ma, Edwin P. Hui, Kwok-Wai Lo, Ka-Fai To, K.C. Allen Chan, Y.M. Dennis Lo, Ann D. King, and Anthony T.C. Chan, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, People's Republic of China; Wan-Teck Lim, National Cancer Centre; Boon-Cher Goh, National University Cancer Institute of Singapore; Alex Y.C. Chang, Johns Hopkins University School of Medicine; Akhil Chopra, OncoCare Cancer Centre, Singapore; Adam Pettinger, Nathan R. Foster, Charles Erlichman, Jun Yin, and Brian A. Costello, Mayo Clinic, Rochester, MN; Jonathan W. Riess, University of California Davis Comprehensive Cancer Center, Sacramento; Barbara J. Gitlitz, University of Southern California Keck School of Medicine, Los Angeles; Dean W. Lim, City of Hope Comprehensive Cancer Center, Duarte, CA; Mark Agulnik, Northwestern University, Evanston, IL; Julie A. Kish and Christine H. Chung, Moffitt Cancer Center, University of South Florida, Tampa, FL; Douglas R. Adkins, Washington University School of Medicine, St Louis, MO; Kevin J. Cullen, University of Maryland, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.0388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941615PMC
May 2018

Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.

Cancer Prev Res (Phila) 2017 Jun 10;10(6):345-354. Epub 2017 Apr 10.

Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/lookup/doi/
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-16-0286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758862PMC
June 2017

Survival analyses in lung cancer.

J Thorac Dis 2016 Nov;8(11):3457-3463

Lungenklinik Heckeshorn, Belin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2016.11.28DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179386PMC
November 2016

A Single-Institution Study of Demographics and Outcomes of Adult Patients With Multiple Cancers.

Cancer Control 2016 Oct;23(4):455-460

Department of Oncology, Mayor Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/107327481602300418DOI Listing
October 2016

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):1099-106

*Division of Biomedical Statistics and Informatics, Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota; †Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona; ‡Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; §Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, North Carolina; ‖Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; ¶Department of Oncology, NCIC Clinical Trials Group, Queen' University, Kingston, ON, Canada; #Department of Hematology & Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia; **Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California; ††Department of Statistics for the Data Center/Operations Office, Japan Clinical Oncology Group Data Center, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan; ‡‡Department of Medical Oncology, Japanese Society of Medical Oncology, Tokyo, Japan; §§Department of Medicine, The University of Chicago Medicine and Biologic Sciences Center, Chicago, Illinois; and ‖‖Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153349
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493926PMC
July 2015

MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial.

PLoS One 2014 13;9(10):e108483. Epub 2014 Oct 13.

Department of Immunology, University of Washington, Seattle, Washington, United States of America; Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, United States of America; Department of Pathology, University of Washington Medical School, Seattle, Washington, United States of America; Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108483PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195600PMC
June 2015

A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321.

J Thorac Oncol 2015 Jan;10(1):172-80

*Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY; †Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; ‡Illinois CancerCare, Peoria, IL; §Hematology/Oncology and **Radiation Oncology, Mayo Clinic, Scottsdale, AZ; ‖Carle Cancer Center Community Clinical Oncology Program, Urbana, IL; ¶Wichita Community Clinical Oncology Program, Wichita, KS; #Oncology and ‡‡Laboratory Medicine and Pathology, and Anatomic Pathology, Mayo Clinic, Rochester, MN; and ††Upstate Carolina CCOP, Spartanburg, SC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320011PMC
January 2015

Patients' rationale for declining participation in a cancer-associated weight loss study.

J Cachexia Sarcopenia Muscle 2014 Jun 13;5(2):121-5. Epub 2014 Mar 13.

Cancer Education Center, Mayo Clinic Cancer Center, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13539-014-0128-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053567PMC
June 2014

Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab.

Pancreas 2014 Apr;43(3):343-9

From the *Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA; †Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ‡Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY; §Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA; ∥Division of Medical Oncology, College of Medicine, The Ohio State University Medical Center, Columbus, OH; ¶Division of Biomedical Statistics and Informatics, Health Sciences Research Department, The Mayo Clinic, Rochester, MN; and #Division of Hematology and Oncology, The Mayo Clinic, Jacksonville, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3955845PMC
April 2014

Obesity is an independent prognostic variable in colon cancer survivors.

Clin Cancer Res 2010 Mar 9;16(6):1884-93. Epub 2010 Mar 9.

Divisions of Oncology and Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-2636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948494PMC
March 2010

Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.

Gastroenterology 2009 Oct 3;137(4):1270-9. Epub 2009 Jul 3.

Miles and Shirley Fiterman Digestive Disease Center, Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2009.06.053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873775PMC
October 2009

Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers.

Clin Cancer Res 2008 Jul;14(13):4128-33

Division of Oncology, Mayo Clinic, Guggenheim 10-11C, 200 1st Street Southwest, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-5160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948489PMC
July 2008

Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.

Clin Cancer Res 2008 Jun;14(11):3408-15

Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street Southwest, 920 Hilton Building, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1489DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674786PMC
June 2008

Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability.

Int J Cancer 2007 Mar;120(6):1232-8

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.22429DOI Listing
March 2007